Design and Challenges
暂无分享,去创建一个
D. Absher | T. Assimes | J. Ioannidis | M. McConnell | E. Ashley | J. Knowles | A. Pavlovic | B. Goldstein | V. Yank | M. Kiernan | Carlos | Bustamante
[1] C McRae,et al. Myocardial infarction. , 2019, Australian family physician.
[2] J. Ioannidis,et al. Consistency of genome-wide associations across major ancestral groups , 2012, Human Genetics.
[3] J. Wardle,et al. Psychological Responses to Genetic Testing for Weight Gain: A Vignette Study , 2012, Obesity.
[4] R. Green,et al. Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: The Genetic Counseling/Lifestyle Change (GC/LC) Study for Diabetes Prevention , 2011, Clinical trials.
[5] N. Mehta. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.
[6] N. Schork,et al. Effect of direct-to-consumer genomewide profiling to assess disease risk. , 2011, The New England journal of medicine.
[7] Donald W. Bowden,et al. Genome-Wide Association Study of Coronary Heart Disease and Its Risk Factors in 8,090 African Americans: The NHLBI CARe Project , 2011, PLoS genetics.
[8] Mark I. McCarthy,et al. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease , 2011, Nature Genetics.
[9] L. Peltonen,et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. , 2010 .
[10] Klaus Mann,et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.
[11] J. Forrester,et al. Redefining normal low-density lipoprotein cholesterol: a strategy to unseat coronary disease as the nation's leading killer. , 2010, Journal of the American College of Cardiology.
[12] Daniel Steinberg,et al. Earlier intervention in the management of hypercholesterolemia: what are we waiting for? , 2010, Journal of the American College of Cardiology.
[13] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[14] Simon C. Potter,et al. Association of the 9p21.3 Locus With Risk of First-Ever Myocardial Infarction in Pakistanis: Case-Control Study in South Asia and Updated Meta-Analysis of Europeans , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[15] Ming D. Li,et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.
[16] D. Lloyd‐Jones. Cardiovascular risk prediction: basic concepts, current status, and future directions. , 2010, Circulation.
[17] Nancy R Cook,et al. Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.
[18] S. Kalichman,et al. A Simple Single-Item Rating Scale to Measure Medication Adherence: Further Evidence for Convergent Validity , 2009, Journal of the International Association of Physicians in AIDS Care.
[19] Michael J. Pencina,et al. Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.
[20] P. O’Reilly,et al. Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.
[21] Andrew D. Johnson,et al. Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.
[22] Theresa M Marteau,et al. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[23] Daniel F. Schwarz,et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3 , 2009, Nature Genetics.
[24] Alberto Piazza,et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.
[25] John P A Ioannidis,et al. Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers , 2009, Circulation. Cardiovascular genetics.
[26] K. Lunetta,et al. Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .
[27] E. Mohler,et al. Ultrasound detection of increased carotid intima-media thickness and carotid plaque in an office practice setting: does it affect physician behavior or patient motivation? , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] M. McCarthy,et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.
[29] Olle Melander,et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. , 2008, The New England journal of medicine.
[30] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[31] K. Furie,et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.
[32] Shaoqi Rao,et al. Four SNPs on Chromosome 9p21 in a South Korean Population Implicate a Genetic Locus That Confers High Cross-Race Risk for Development of Coronary Artery Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[33] Kari Stefansson,et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. , 2007, Science.
[34] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[35] J. Gulcher,et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.
[36] Marcia M. Nizzari,et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.
[37] M. Jarvelin,et al. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.
[38] Jonathan C. Cohen,et al. A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.
[39] T. Hudson,et al. A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.
[40] Lawrence A Leiter,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines , 2006, Current opinion in cardiology.
[41] M. Budoff,et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. , 2006, Atherosclerosis.
[42] Ralph B D'Agostino,et al. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.
[43] J. Austoker,et al. The psychological impact of mammographic screening on women with a family history of breast cancer—a systematic review , 2005, Psycho-oncology.
[44] J. Kastelein,et al. Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. , 2003, Archives of internal medicine.
[45] U. P. S. T. Force,et al. Measuring Quality: Are We Ready To Compare the Quality of Care among Physician Groups? , 2002, Annals of Internal Medicine.
[46] S M Grundy,et al. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.
[47] J. Weinman,et al. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.
[48] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.
[49] Victor J. Strecher,et al. Do cigarette smokers have unrealistic perceptions of their heart attack, cancer, and stroke risks? , 1995, Journal of Behavioral Medicine.
[50] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[51] J. Prochaska,et al. Stages and processes of self-change of smoking: toward an integrative model of change. , 1983, Journal of consulting and clinical psychology.
[52] Russell E Glasgow,et al. Starting the conversation performance of a brief dietary assessment and intervention tool for health professionals. , 2011, American journal of preventive medicine.
[53] Tanya M. Teslovich,et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .
[54] A. R. Miller. The CaReS Battery: Measuring Stages of Change in Cardiac Rehabilitation through the Development of a Targeted Instrument , 2010 .
[55] R. Collins,et al. Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.
[56] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[57] V. Strecher,et al. Changing inaccurate perceptions of health risk: results from a randomized trial. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[58] G. Abecasis,et al. Supporting Online Material Materials and Methods Figs. S1 to S8 Tables S1 to S10 References a Genome-wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2022 .